Neurovascular Devices Market: By Device Type (Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Support Devices and Clot Retrieval), By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others), By End User (Hospitals, Clinics and Ambulatory Surgical Centers) and Geography  

Neurovascular Devices Market size was valued at 2.69 Billion in 2022 and is estimated to reach 4.69 Billion by 2029, at a CAGR of 7.4% from 2023 to 2029. Some of the factors propelling the market growth to the rising geriatric population they have a greater risk to prone various diseases and disorders such as cerebrovascular, neurological, and others. Additionally, accessibility to advanced medical facilities for diagnosis and treatment will positively impact the market growth. Furthermore, upgrading in technology and new advanced innovations in the medical facility will fuel the market growth. However, the high cost of the treatment, lack of skilled professionals, and lack of awareness among the individuals will hinder the market growth. Aneurysms are caused by an increase in the prevalence of hypertension, alcohol intake, and smoking. An estimated 6 million Americans are impacted by brain aneurysms each year, according to the Brain Aneurysm Foundation. Every year, the disease claims the lives of half a million people around the world. In the creation of neurothrombectomy devices for the treatment of AIS and accompanying symptoms, a variety of additional technologies are applied. As a result, market expansion is likely to be fueled by the launch of technologically improved items and a quick product approval procedure.